Cargando…
Adverse outcomes with extracorporeal adsorbent blood treatments in toxic systemic inflammation: a perspective on possible mechanisms
BACKGROUND: Extracorporeal blood purification (EBP) treatments may be used in patients with sepsis and related conditions to mitigate toxic systemic inflammation, prevent or reverse vital organ injury, and improve outcome. These treatments lack demonstrable efficacy, but are generally considered saf...
Autores principales: | Matson, James, Lange, Paul, Honore, Patrick M., Chung, Kevin K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652582/ https://www.ncbi.nlm.nih.gov/pubmed/36370238 http://dx.doi.org/10.1186/s13613-022-01078-6 |
Ejemplares similares
-
A Review of Extracorporeal Blood Purification Techniques for the Treatment of Critically Ill Coronavirus Disease 2019 Patients
por: Niazi, Nicholas S., et al.
Publicado: (2022) -
Bioinspired detoxification of blood: The efficient removal of anthrax toxin protective antigen using an extracorporeal macroporous adsorbent device
por: Ingavle, Ganesh, et al.
Publicado: (2018) -
In-Depth Analysis of the Extracorporeal Proteome Adsorbed to Dialysis Membranes during Hemodialysis
por: Daniel-Fischer, Lisa, et al.
Publicado: (2022) -
Chitin Adsorbents for Toxic Metals: A Review
por: Anastopoulos, Ioannis, et al.
Publicado: (2017) -
Extracorporeal endotoxin adsorbent therapy in the critically ill patients with COVID-19 during ECMO
por: Fu, Bao, et al.
Publicado: (2023)